Jobs / United States / Glaxosmithkline LLC
ViiV Healthcare (GSK) Senior Director, Pipeline and Product Communications
Glaxosmithkline LLC · 🇺🇸 USA - North Carolina - Durham
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Product Director, Platform API” (Information Technology Project Managers) in TX: $149k–$149k, median $149k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
ViiV Healthcare is a global specialist HIV company, 100% focused on researching, developing and delivering innovative medicines to treat and prevent HIV. With a broad portfolio of licensed medicines, a rich pipeline, the only dedicated HIV research facility in the USA and cutting-edge innovation partnerships, ViiV is entering a pivotal period of transformation. The company continues to lead the long-acting transformation in HIV while preparing to launch a series of exciting new products across treatment and prevention, creating a significant opportunity to build confidence in ViiV’s science, portfolio and pipeline; strengthen internal belief in the company’s direction; and reinforce ViiV’s leadership with external stakeholders and the HIV community, to become the Long-Acting Injectable (LAI) Powerhouse. The Senior Director, Pipeline and Product Communications owns the global communications strategy for ViiV’s industry-leading pipeline and portfolio and setting clear priorities for how the company communicates its most important scientific, portfolio and launch milestones. The role reports into the Head of Global Communications and partners closely with regional communications leads for priority assets and launches and positions ViiV as a leader in long-acting HIV innovation. As senior communications business partner to the SVP Head of R&D and SVP Chief Medical Officer, the role provides strategic counsel on reputation, scientific storytelling, disclosure readiness and issues management, translating complex science into meaningful, business-relevant narratives for internal and external audiences. The role is accountable for integrated strategic communications plans aligned to ViiV’s pipeline and portfolio priorities, ensuring consistent, high-impact news flow around data, regulatory milestones, scientific congresses and other key moments. As ViiV prepares for upcoming treatment and prevention launches, this role will steward communications that build momentum, partner with scientific communications on publication planning and data dissemination, differentiate ViiV and stakeholder confidence and contribute to the ambition of becoming the LAI Powerhouse. This is a senior leadership role requiring strong scientific understanding, credibility with senior stakeholders, strategic judgment and the ability to lead through complexity. The role leads the Pipeline and Product Communications team and works in close partnership with the broader ViiV Global Communications team, ViiV US Communications team, R&D, Medical, GSK Communications, Investor Relations and agency partners. It requires the ability to prioritise, influence and deliver at pace across complex, concurrent projects, while setting the operating model for pipeline and product communications and identifying the moments that matter most for ViiV’s reputation, launch readiness and transformation into the LAI Powerhouse. This role will be based out of Durham, NC & may be considered for a domestic relocation package. Check out this link to learn more about the thriving, diverse, and cutting edge RTP area! Research Triangle Park | Where People + Ideas Converge (rtp.org) This role is hybrid, combining in-office collaboration in the United States with remote working flexibility. Responsibilities This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: • Lead the global pipeline and product communications strategy, setting priorities, and a clear communications cadence for internal and external communications that showcase ViiV’s science and innovation, build confidence in the long-acting portfolio and pipeline, and support the company’s transformation into the LAI Powerhouse. • Act as senior